Samsara BioCapital, LLC - PRIME MEDICINE INC ownership

PRIME MEDICINE INC's ticker is and the CUSIP is 74168J101. A total of 84 filers reported holding PRIME MEDICINE INC in Q3 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
Samsara BioCapital, LLC ownership history of PRIME MEDICINE INC
ValueSharesWeighting
Q3 2023$4,486,700
-34.9%
470,3040.0%1.37%
+13.6%
Q2 2023$6,889,954
+19.1%
470,3040.0%1.21%
+1.1%
Q1 2023$5,784,739
-33.8%
470,3040.0%1.20%
-36.4%
Q4 2022$8,738,248470,3041.88%
Other shareholders
PRIME MEDICINE INC shareholders Q3 2023
NameSharesValueWeighting ↓
MWG Management Ltd. 1,792,210$17,097,68316.57%
Alphabet Inc. 11,862,498$113,168,2307.27%
Samsara BioCapital, LLC 470,304$4,486,7001.37%
Redmile Group, LLC 1,324,350$12,634,2990.60%
BRANDYWINE MANAGERS, LLC 32,977$314,6010.53%
Greenwich Wealth Management LLC 439,021$4,1880.44%
Nikko Asset Management Americas, Inc. 3,634,848$34,567,4040.41%
Casdin Capital, LLC 367,175$3,502,8500.39%
Green Alpha Advisors, LLC 37,815$360,7550.28%
EcoR1 Capital, LLC 600,000$5,724,0000.19%
View complete list of PRIME MEDICINE INC shareholders